4.3.1.B2	6-diazo-5-oxo-L-norleucine	-	839	
4.3.1.B2	acivicin	-	2824	
4.3.1.B2	albizziin	mixed type inhibition versus N1-[(5'-phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamido-1-beta-D-ribofuranosyl 5'-phosphate, competitive inhibition versus L-glutamine	10572	
4.3.1.B2	MgCl2	10 mM, activity is reduced by 22%	196	
4.3.1.B2	MnCl2	10 mM, activity is reduced by 58%	307	
4.3.1.B2	N1-[(5'-phosphoarabinitolyl)-formimino]-5-aminoimidazole-4-carboxamide ribonucleotide	competitive versus N1-[(5'-phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamido-1-beta-D-ribofuranosyl 5'-phosphate, mixed type inhibition versus L-glutamine	194448	
4.3.1.B2	N1-[(5'-phosphoribitolyl)-formimino]-5-aminoimidazole-4-carboxamide ribonucleotide	competitive versus N1-[(5'-phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamido-1-beta-D-ribofuranosyl 5'-phosphate	194449